메뉴 건너뛰기




Volumn 144, Issue 8, 2016, Pages 1088-1092

Lymphocytic colitis in a patient with ulcerative colitis. Report of one case;Colitis linfocítica en paciente con colitis ulcerosa. Caso clínic

Author keywords

Colitis; Inflammatory bowel diseases; Lymphocytic; Microscopic; Ulcerative

Indexed keywords

CALGRANULIN;

EID: 84998953398     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/s0034-98872016000800019     Document Type: Article
Times cited : (2)

References (17)
  • 6
    • 84939817931 scopus 로고    scopus 로고
    • Microscopic colitis: A review of etiology, treatment and refractory disease
    • Park T, Cave D, Marshall C. Microscopic colitis: A review of etiology, treatment and refractory disease. World J Gastroenterol 2015; 21: 8804-10.
    • (2015) World J Gastroenterol , vol.21 , pp. 8804-8810
    • Park, T.1    Cave, D.2    Marshall, C.3
  • 8
    • 0345802746 scopus 로고    scopus 로고
    • Collagenous colitis evolving into ulcerative colitis: A case report and review of the literature
    • Aqel B, Bishop M, Krishna M, Cangemi J. Collagenous colitis evolving into ulcerative colitis: a case report and review of the literature. Dig Dis Sci 2003; 48(12): 2323-7.
    • (2003) Dig Dis Sci , vol.48 , Issue.12 , pp. 2323-2327
    • Aqel, B.1    Bishop, M.2    Krishna, M.3    Cangemi, J.4
  • 9
    • 35349003681 scopus 로고    scopus 로고
    • Progression of ulcerative colitis to collagenous colitis: Chance, evolution or association?
    • Haque M, Florin T. Progression of ulcerative colitis to collagenous colitis: chance, evolution or association? Inflamm Bowel Dis 2007; 13: 1321.
    • (2007) Inflamm Bowel Dis , vol.13 , pp. 1321
    • Haque, M.1    Florin, T.2
  • 11
    • 58149188885 scopus 로고    scopus 로고
    • Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease
    • Wagner M, Peterson CG, Ridefelt P, Sangfelt P, Carlson M. Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease. World J Gastroenterol 2008; 14: 5584-9.
    • (2008) World J Gastroenterol , vol.14 , pp. 5584-5589
    • Wagner, M.1    Peterson, C.G.2    Ridefelt, P.3    Sangfelt, P.4    Carlson, M.5
  • 12
    • 76049109946 scopus 로고    scopus 로고
    • Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: A multicenter prospective study
    • Meuccia G, D’Incàc R, Maieronb R, Orzesf N, Vecchid M, Visentinie D, et al. Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: A multicenter prospective study. Dig Liver Dis 2010; 42: 191-5.
    • (2010) Dig Liver Dis , vol.42 , pp. 191-195
    • Meuccia, G.1    D’Incàc, R.2    Maieronb, R.3    Orzesf, N.4    Vecchid, M.5    Visentinie, D.6
  • 13
    • 84859635560 scopus 로고    scopus 로고
    • Fecal markers: Calprotectin and lactoferrin
    • Abraham BP, Kane S. Fecal markers: Calprotectin and lactoferrin. Gastroenterol Clin North Am 2012; 41(2): 483-95.
    • (2012) Gastroenterol Clin North Am , vol.41 , Issue.2 , pp. 483-495
    • Abraham, B.P.1    Kane, S.2
  • 14
    • 15444376847 scopus 로고    scopus 로고
    • Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis
    • Andresen L, Jørgensen VL, Perner A, Hansen A, Eugen-Olsen J, Rask-Madsen J. Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis. Gut 2005; 54: 503-9.
    • (2005) Gut , vol.54 , pp. 503-509
    • Andresen, L.1    Jørgensen, V.L.2    Perner, A.3    Hansen, A.4    Eugen-Olsen, J.5    Rask-Madsen, J.6
  • 15
    • 60749103324 scopus 로고    scopus 로고
    • Interventions for treating microscopic colitis: A Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials
    • Chande N, MacDonald JK, McDonald JW. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol 2009; 104: 235-41.
    • (2009) Am J Gastroenterol , vol.104 , pp. 235-241
    • Chande, N.1    Macdonald, J.K.2    McDonald, J.W.3
  • 16
    • 85012113480 scopus 로고    scopus 로고
    • Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis
    • Naganuma M, Aoyama N, Suzuki Y, Nishino H, Kobayashi K, Hirai F, et al. Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis. J Crohns Colitis 2015 Nov 16. pii: jjv208. [Epub ahead of print].
    • (2015) J Crohns Colitis
    • Naganuma, M.1    Aoyama, N.2    Suzuki, Y.3    Nishino, H.4    Kobayashi, K.5    Hirai, F.6
  • 17
    • 84946426642 scopus 로고    scopus 로고
    • Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis
    • Lichtenstein GR Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis. Dig Dis Sci 2016; 61: 358-70.
    • (2016) Dig Dis Sci , vol.61 , pp. 358-370
    • Lichtenstein, G.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.